March 19, 2021
Vaccine hesitancy and variants challenge efforts to tame COVID-19
The Janssen Biotech, Inc/Johnson & Johnson COVID-19 vaccine received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) on February 27, joining the Pfizer-BioNTech and Moderna vaccines that received EUA in December 2020.
Free Daily News
- Biden administration expands HHS authority to bolster US medical supply chain
- FTC lawsuit challenges private equity medical group ‘Roll-Up’ deals
- Functional ultrasound offers less invasive option for people with paralysis
- Balanced IV solutions may benefit critically ill patients
- ASCs continue to contend with anesthesia provider shortages, inflating costs
- Study: VR technology helps reduce patient anxiety prior to surgery
- Researchers develop new early stage breast cancer detection device
- Proposed bill seeks to end costly insurance fees on electronic healthcare payments
- Research indicates CAB sequence yields best results in trauma patients
- Stronger quads shown to reduce need for knee replacement surgery
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging